Quest Diagnostics Incorporated (DGX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Quest Diagnostics Incorporated (DGX) is Neutral.

The composite score behind that read is +0.01, weighing +0.20 of bullish evidence against -0.35 bearish.

Quest Diagnostics Incorporated last closed at $230.97, +0.07% on the session.

Against the IVW growth benchmark the position is -0.73% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

11 graded predictions for DGX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Quest Diagnostics Incorporated in the 37th percentile on valuation and the 71st percentile on return on equity, where 100 is best.

Quest Diagnostics Incorporated is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $25.48B.

StockMap tracks Quest Diagnostics Incorporated as the 12th largest of the 85 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 81 Neutral and 4 Moderate Underperform.

On that composite Quest Diagnostics Incorporated ranks 37th of 85 in the group, against a group median of +0.00.